세계의 전자 처방 시장 보고서(2025년)
E-Prescribing Global Market Report 2025
상품코드 : 1821550
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

전자 처방 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 81억 4,000만 달러로 성장하고 CAGR은 25.2%를 나타낼 전망입니다. 예측 기간의 성장은 원격 의료 부문의 성장, 맞춤형 의료, 처방약 모니터링 프로그램, 약물 치료 관리, 세계 전자 처방 이니셔티브에 기인합니다. 예측기간의 주요 동향에는 상호운용성과 의료정보교환, 투약조합, 전자사전승인, 복약어드어런스툴, 규제약제용 ERX, AI 주도형 경보, 의사결정 지원 등이 포함됩니다.

향후 5년간의 성장률 25.2%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 캐나다와 이스라엘에서 개발된 전자 처방 소프트웨어 인터페이스 및 수식 데이터베이스 가격을 올리고 의료 현장 관리 비용을 증가시켜 의약품의 안전성을 저해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가에 의한 세계경제와 무역에 대한 악영향에 의해 그 영향은 보다 넓게 느껴진다고 생각됩니다.

전자 처방 시장은 주로 의료 과오의 감소에 중점을 두게 되어 성장이 전망되고 있습니다. 의료 과오는 피할 수 있었던 의료적 부작용을 포함하는데 전자 처방에 의해 특히 의사의 알아보기 힘든 필체로 인한 오류를 줄이는 데 있어 크게 완화되었습니다. 이러한 에러를 최소화하는 것이 전자 처방 시장의 확대를 뒷받침하는 중요한 요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

E-prescribing is a technological system that facilitates the electronic creation and transmission of prescriptions from healthcare providers, such as physicians, to participating pharmacies. This method eliminates the need for handwritten or faxed prescriptions and enables a more efficient and secure process.

In the realm of e-prescribing, components are broadly categorized into solutions and services. Services, in this context, denote intangible, non-physical elements within the economy, distinct from tangible goods. Deployment of e-prescribing systems can take place through web-based, cloud-based, or on-premise approaches. The end-users of e-prescribing systems include hospitals, office-based physicians, and pharmaceutical entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The e-prescribing market research report is one of a series of new reports from The Business Research Company that provides e-prescribing market statistics, including e-prescribing industry global market size, regional shares, competitors with an e-prescribing market share, detailed e-prescribing market segments, market trends and opportunities, and any further data you may need to thrive in the e-prescribing industry. This e-prescribing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The e-prescribing market size has grown exponentially in recent years. It will grow from $2.67 billion in 2024 to $3.31 billion in 2025 at a compound annual growth rate (CAGR) of 24.2%. The growth in the historic period can be attributed to regulatory mandates, medication errors reduction, improved patient safety, enhanced prescription workflow, increased prescriber efficiency.

The e-prescribing market size is expected to see exponential growth in the next few years. It will grow to $8.14 billion in 2029 at a compound annual growth rate (CAGR) of 25.2%. The growth in the forecast period can be attributed to growing telemedicine sector, personalized medicine, prescription drug monitoring programs, medicationTherapy management, global e-prescribing initiatives. Major trends in the forecast period include interoperability and health information exchange, medication reconciliation, electronic prior authorization, medication adherence tools, erx for controlled substances, ai-driven alerts and decision support.

The forecast of 25.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder medication safety by inflating prices of e-prescribing software interfaces and formulary databases developed in Canada and Israel, increasing administrative costs for medical practices. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The e-prescribing market is poised for growth, primarily driven by an increased emphasis on reducing medical errors. Medical errors, avoidable adverse effects of medical care, have been significantly mitigated by e-prescribing, particularly in addressing issues arising from illegible physician handwriting. Notably, in May 2023, the National Library of Medicine reported that medical errors in hospitals and clinics contribute to the deaths of approximately 100,000 people annually in the United States. The imperative to minimize such errors is a key factor propelling the expansion of the e-prescribing market.

The e-prescribing market is anticipated to experience substantial growth with the increasing adoption of telehealth and telemedicine. Telehealth, leveraging telecommunications technology for remote healthcare services, and telemedicine, specifically enabling remote clinical consultations, synergize with e-prescribing to streamline prescription processes, enhance efficiency, and boost patient engagement. The integration of e-prescribing with telehealth platforms allows healthcare providers to electronically transmit prescriptions to pharmacies, reducing errors, enhancing patient safety, and providing convenient access to medications. Notably, according to the Centers for Disease Control and Prevention in October 2022, 37.0% of adults utilized telemedicine within the preceding 12 months in 2021. This surge in telehealth adoption is a key driver for the anticipated growth of the e-prescribing market.

A significant trend in the e-prescribing market is the technological transformation in healthcare. Leading companies in the sector are actively pursuing the development of innovative technological solutions to fortify their market position. A notable example is Change Healthcare, a US-based healthcare technology company, which, in April 2022, introduced InterQual 2022. This latest edition of their clinical decision support solution incorporates updated criteria for emergent trends, streamlined and interactive workflows, and artificial intelligence (AI) for proactive insights and efficiency. The integration of unbiased and peer-reviewed criteria demonstrates a commitment to advancing technology within the e-prescribing landscape.

Prominent players in the e-prescribing market are actively engaged in the development of novel solutions for e-prescribing networks, positioning themselves strategically to secure a competitive advantage. An e-prescribing network serves as a digital platform facilitating the electronic exchange of prescription information among healthcare professionals, pharmacies, and payers. In a notable development in March 2022, First Databank Inc., a US-based healthcare company, introduced FDB Vela, a cloud-native electronic prescribing network. This innovative platform enables seamless communication of critical medication prescription information, benefits verification, and clinical decision support across diverse healthcare stakeholders, including prescribers, payers, pharmacies, and technology partners. FDB Vela emphasizes accessibility, easy onboarding, and advanced functionalities, offering a non-exclusive and straightforward avenue for participants to streamline the prescribing and fulfillment processes. This approach aims to enhance patient care and foster collaborative innovation within the healthcare industry.

In March 2023, PRN Software, LLC, a U.S.-based healthcare software company, acquired Bravado Health for an undisclosed amount. This acquisition allows PRN Software to expand its ePrescribing solutions, enhance patient safety and compliance, drive innovation and growth, and provide better support for healthcare providers. Bravado Health is a U.S.-based digital health technology company that improves patient care by integrating e-prescribing into its digital health platform.

Major companies operating in the e-prescribing market include Epic Systems Corporation, Allscripts Healthcare Solutions Inc., NextGen Healthcare Inc., Athenahealth, Henry Schein Inc., Computer Programs and Systems Inc., DrFirst.com Inc., Surescripts, Medical Information Technology, Change Healthcare, Health Fusion Inc., eMDs Inc., Cerner Corporation, Practice Fusion Inc., eClinicalWorks LLC, Greenway Health LLC, AdvancedMD Inc., Kareo Inc., PracticeSuite Inc., Advanced Data Systems Corporation, Aprima Medical Software Inc., Compulink Healthcare Solutions, CureMD Healthcare, MacPractice Inc., Medsphere Systems Corporation, Modernizing Medicine Inc., NueMD LLC, Office Ally Inc., Optum Inc., PatientNOW Inc., protected cell company, Sevocity Inc.

North America was the largest region in the e-prescribing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the e-prescribing market during the forecast period. The regions covered in the global e-prescribing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the e-prescribing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The e-prescribing market consists of sales of software and services related to software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

E-Prescribing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on e-prescribing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for e-prescribing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The e-prescribing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. E-Prescribing Market Characteristics

3. E-Prescribing Market Trends And Strategies

4. E-Prescribing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global E-Prescribing Growth Analysis And Strategic Analysis Framework

6. E-Prescribing Market Segmentation

7. E-Prescribing Market Regional And Country Analysis

8. Asia-Pacific E-Prescribing Market

9. China E-Prescribing Market

10. India E-Prescribing Market

11. Japan E-Prescribing Market

12. Australia E-Prescribing Market

13. Indonesia E-Prescribing Market

14. South Korea E-Prescribing Market

15. Western Europe E-Prescribing Market

16. UK E-Prescribing Market

17. Germany E-Prescribing Market

18. France E-Prescribing Market

19. Italy E-Prescribing Market

20. Spain E-Prescribing Market

21. Eastern Europe E-Prescribing Market

22. Russia E-Prescribing Market

23. North America E-Prescribing Market

24. USA E-Prescribing Market

25. Canada E-Prescribing Market

26. South America E-Prescribing Market

27. Brazil E-Prescribing Market

28. Middle East E-Prescribing Market

29. Africa E-Prescribing Market

30. E-Prescribing Market Competitive Landscape And Company Profiles

31. E-Prescribing Market Other Major And Innovative Companies

32. Global E-Prescribing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The E-Prescribing Market

34. Recent Developments In The E-Prescribing Market

35. E-Prescribing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기